Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Other financing activities (2016 - 2025)

Bruker's Other financing activities history spans 11 years, with the latest figure at -$9.4 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 44.71% year-over-year to -$9.4 million; the TTM value through Dec 2025 reached -$8.3 million, up 66.67%, while the annual FY2025 figure was -$8.3 million, 66.67% up from the prior year.
  • Other financing activities reached -$9.4 million in Q4 2025 per BRKRP's latest filing, down from $6.5 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $10.6 million in Q4 2022 to a low of -$17.0 million in Q4 2024.
  • Average Other financing activities over 4 years is -$2.2 million, with a median of -$1.5 million recorded in 2023.
  • Peak YoY movement for Other financing activities: tumbled 431.25% in 2024, then surged 822.22% in 2025.
  • A 4-year view of Other financing activities shows it stood at $10.6 million in 2022, then tumbled by 130.19% to -$3.2 million in 2023, then crashed by 431.25% to -$17.0 million in 2024, then surged by 44.71% to -$9.4 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Other financing activities are -$9.4 million (Q4 2025), $6.5 million (Q3 2025), and -$4.3 million (Q2 2025).